文献速递慢性肾脏病肾血管病与高血压

认知功能与肾脏疾病:SPRINT试验基线数据

Cognitive Function and Kidney Disease: Baseline Data From the Systolic Blood Pressure Intervention Trial (SPRINT).
PubMed 文献 · Am J Kidney Dis · 2017-06-09

本研究为SPRINT试验的横断面分析,纳入2707例接受神经认知测试的老年参与者,评估尿白蛋白肌酐比(ACR)和估算肾小球滤过率(eGFR)与认知功能及脑白质异常的关系。结果显示,较高ACR与整体认知、执行功能、记忆和注意力较差相关,较低eGFR与整体认知和记忆较差独立相关;较高ACR而非eGFR与更大异常白质体积相关。

要点

  • 较高尿ACR与多个认知域表现较差相关,效应相当于年龄增加数月至一年多。
  • 较低eGFR独立与整体认知和记忆较差相关。
  • 较高ACR而非eGFR与更大异常脑白质体积相关,提示血管病变可能介导。

核心结论

  • 在无糖尿病的老年人群中,较高尿ACR和较低eGFR分别与整体认知表现独立相关,且影响不同认知域。
  • 白蛋白尿同时与更高负担的异常脑白质病变相关,提示血管疾病可能介导这些关系。

研究设计与样本

  • 横断面队列研究,使用SPRINT试验基线数据。
  • 共9361例SPRINT参与者,其中2800例参与SPRINT-MIND子研究,2707例有完整数据,637例完成脑磁共振成像。
  • 平均年龄68岁,37%为女性,30%为黑人,20%有已知心血管疾病。

主要发现

  • 平均eGFR为70.8±20.9 mL/min/1.73m²,尿ACR中位数为9.7(IQR 5.7-22.5)mg/g。
  • 调整分析中,尿ACR每翻倍与整体认知、执行功能、记忆和注意力表现较差的关联分别相当于年龄增加7、10、6和14个月。
  • 较低eGFR独立与整体认知功能和记忆较差相关。
  • 调整模型中,较高ACR而非eGFR与更大异常白质体积相关。

临床怎么用

  • 在老年无糖尿病患者中,评估尿ACR和eGFR有助于识别认知功能下降风险较高的个体。
  • 白蛋白尿可能提示脑血管病变负担,可考虑结合脑影像评估。

局限性

  • 横断面设计,无法推断因果关系。
  • 未纳入糖尿病患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic kidney disease is common and is associated with cardiovascular disease, cerebrovascular disease, and cognitive function, although the nature of this relationship remains uncertain. STUDY DESIGN: Cross-sectional cohort using baseline data from the Systolic Blood Pressure Intervention Trial (SPRINT). SETTING & PARTICIPANTS: Participants in SPRINT, a randomized clinical trial of blood pressure targets in older community-dwelling adults with cardiovascular disease, chronic kidney disease, or high cardiovascular disease risk and without diabetes or known stroke, who underwent detailed neurocognitive testing in the cognition substudy, SPRINT-Memory and Cognition in Decreased Hypertension (SPRINT-MIND). PREDICTORS: Urine albumin-creatinine ratio (ACR) and estimated glomerular filtration rate (eGFR). OUTCOMES: Cognitive function, a priori defined as 5 cognitive domains based on 11 cognitive tests using z scores, and abnormal white matter volume quantified by brain magnetic resonance imaging. RESULTS: Of 9,361 SPRINT participants, 2,800 participated in SPRINT-MIND and 2,707 had complete data; 637 had brain imaging. Mean age was 68 years, 37% were women, 30% were black, and 20% had known cardiovascular disease. Mean eGFR was 70.8±20.9mL/min/1.73m2 and median urine ACR was 9.7 (IQR, 5.7-22.5) mg/g. In adjusted analyses, higher ACR was associated with worse global cognitive function, executive function, memory, and attention, such that each doubling of urine ACR had the same association with cognitive performance as being 7, 10, 6, and 14 months older, respectively. Lower eGFR was independently associated with worse global cognitive function and memory. In adjusted models, higher ACR, but not eGFR, was associated with larger abnormal white matter volume. LIMITATIONS: Cross-sectional only, no patients with diabetes were included. CONCLUSIONS: In older adults, higher urine ACR and lower eGFR have independent associations with global cognitive performance with different affected domains. Albuminuria concurrently identifies a higher burden of abnormal brain white matter disease, suggesting that vascular disease may mediate these relationships.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Weiner DE, Gaussoin SA, Nord J, et al. Cognitive Function and Kidney Disease: Baseline Data From the Systolic Blood Pressure Intervention Trial (SPRINT). Am J Kidney Dis. 2017. PMID: 28606731. doi:10.1053/j.ajkd.2017.04.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。